跳转至内容
Merck
CN

53849-U

Ascentis® Express 90Å C8 (2.7 μm) HPLC Columns

L × I.D. 7.5 cm × 3 mm, HPLC Column

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

UNSPSC Code:
41115700
eCl@ss:
32110501
NACRES:
SB.52
L × i.d.:
7.5 cm × 3 mm
Particle size:
2.7 μm
Matrix active group:
C8 (octyl) phase
Pore size:
90 Å
Matrix:
Fused-Core particle platform, superficially porous particle
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


产品名称

Ascentis ® Express C8,2.7μm HPLC 色谱柱, 2.7 μm particle size, L × I.D. 7.5 cm × 3 mm

material

stainless steel column

Quality Level

agency

suitable for USP L7

product line

Ascentis®

feature

endcapped

manufacturer/tradename

Ascentis®

packaging

1 ea of

parameter

60 °C temp. range, 600 bar max. pressure (9000 psi)

technique(s)

HPLC: suitable, LC/MS: suitable, UHPLC-MS: suitable, UHPLC: suitable

L × I.D.

7.5 cm × 3 mm

surface area

135 m2/g

impurities

<5 ppm metals

matrix

Fused-Core particle platform, superficially porous particle

matrix active group

C8 (octyl) phase

particle size

2.7 μm

pore size

90 Å

operating pH range

2-9

application(s)

food and beverages

separation technique

reversed phase

General description

通过使用Fused-Core® 粒子技术,Ascentis Express HPLC色谱柱在保持较低的反压力的同时,可以为您提供2μm以下颗粒的高速和高效率。高效率和低背压的结合可使UPLC® (或其他超高压系统)用户,以及常规HPLC用户受益。
访问 Ascentis Express 主页,以获得有关此新色谱柱技术的更多信息。

Legal Information

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany
Fused-Core is a registered trademark of Advanced Materials Technology, Inc.
UPLC is a registered trademark of Waters


Still not finding the right product?


存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库


商品

When a C18 doesn′t give the desired separation, or your sample contains compounds that are known to be difficult to retain or resolve on a C18, consider changing to an Ascentis® Express C8 column.


Ugandar Reddy Inugala et al.
Journal of chromatographic science, 51(5), 453-459 (2012-10-13)
This paper describes the development of a rapid, novel, stability-indicating gradient reversed-phase high-performance liquid chromatographic method and associated system suitability parameters for the analysis of naproxcinod in the presence of its related substances and degradents using a quality-by-design approach. All
Sreenivasa Rao Chitturi et al.
Journal of pharmaceutical and biomedical analysis, 55(1), 31-47 (2011-02-15)
This paper proposes a simple and selective RP-HPLC method for the determination of process impurities and degradation products (degradants) of atazanavir sulfate (ATV) drug substance. Chromatographic separation was achieved on Ascentis(®) Express C8, (150mm×4.6mm, 2.7μm) column thermostated at 30°C under
Luigi Silvestro et al.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 878(30), 3134-3142 (2010-10-20)
Quantitative methods using LC-MS/MS allow achievement of adequate sensitivity for pharmacokinetic studies with clopidogrel; three such methods, with LLOQs as low as 5 pg/mL, were developed and fully validated according to the well established FDA 2001 guidelines. The chromatographic separations



全球贸易项目编号

货号GTIN
53849-U04061838534439
1012796500104061838667588
1012798100104061838667595
481911-10GM07790788050689
43410-1G04061832110950
43410-250MG04061832110967
43410-5G04061832111117
N3014-100MG04061834115649
N3014-5G04061833612323
N1511-250MG04061834109433
N3014-1G04061835513901
N6522-250MG04061834117605
N7004-10G04061835547074
N7381-12G04061834117988
N7381-20G04061835516704
N7381-12X600MG04061833612361
N1636-1G04061834109624
N8285-15VL04061834118503
N8535-15VL04061835558186